Can we stop prostate specific antigen testing 10 years after radical prostatectomy?

Journal of Urology

Volumn 186, Issue 2, 2011, Pages 500-505

  Loeb, Stacy ^a   Feng, Zhaoyong ^a   Ross, Ashley ^a   Trock, Bruce J ^a   Humphreys, Elizabeth B ^a   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

prostatectomy; prostatic neoplasms; recurrence; time factors

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIGITAL RECTAL EXAMINATION; DISEASE FREE INTERVAL; GLEASON SCORE; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY; RECURRENT DISEASE; RISK; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 79960183335     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.116     Document Type: Article

References (10)

1. T.A. Stamey, N. Yang, and A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
2. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
3. M. Han, A.W. Partin, and C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555
4. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766
5. C.L. Amling, M.L. Blute, and E.J. Bergstralh Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years J Urol 164 2000 101
6. A.A. Caire, L. Sun, and O. Ode Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes? Urology 74 2009 643
7. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology http://www.nccn.org/professionals/physician-gls/PDF/prostate.pdf Accessed January 21, 2009
8. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005
9. M.K. Tollefson, M.L. Blute, and L.J. Rangel Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy J Urol 184 2010 925
10. D.A. Ahove, K.E. Hoffman, and J.C. Hu Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?implications for a risk-adapted follow-up strategy Urology 76 2010 1201